Frojmovic M M, Wong T, Searcy G P
Department of Physiology, McGill University, Montreal, Quebec, Canada.
Thromb Haemost. 1996 Dec;76(6):1047-52.
We have previously reported that platelets from bleeding Simmental cattle do not aggregate in vitro in response to ADP, collagen and calcium ionophore A23187, though calcium mobilization and myosin light chain phosphorylation do occur. The aggregation abnormality, measured by aggregometry, was ascribed to abnormal cytoskeletal expression, with the maximal numbers of activated GpIIb-IIIa receptors per platelet no different from that seen in normal bovine platelets activated with ADP. We have therefore sought to compare the kinetics of micro-aggregation with the rate of expression of GpIIb-IIIa receptors required for mediating fibrinogen (Fg)-dependent platelet aggregation, to provide a more direct molecular explanation for the aggregation abnormality. We compared aggregation kinetics of ADP-activated platelets using both aggregometry and particle counting to monitor micro-aggregation. Fibrinogen receptor expression was monitored with FITC-labelled human Fg and with the reporting antibody for activated GpIIb-IIIa, FITC-PAC1, using flow cytometry. The affected platelets show a marked delay in onset of microaggregation for ADP-activated platelets stirred with human Fg, paralleded by an unusual delay in activated GpIIb-IIIa receptor expression (DARE) for otherwise competent Fg binding. The on-rates for Fg binding to platelets maximally pre-activated with PMA are identical for normal and affected platelets, whether comparing the binding of human or bovine Fg. The unique DARE syndrome explains the observed delay in aggregation of platelets from affected Simmental cattle and predicts the bleeding problems due to delayed binding of adhesive proteins.
我们之前报道过,西门塔尔牛出血时的血小板在体外对ADP、胶原和钙离子载体A23187不发生聚集,尽管会出现钙动员和肌球蛋白轻链磷酸化。通过血小板聚集仪测量的聚集异常归因于细胞骨架表达异常,每个血小板上活化的糖蛋白IIb-IIIa受体的最大数量与用ADP活化的正常牛血小板中的数量没有差异。因此,我们试图比较微聚集动力学与介导纤维蛋白原(Fg)依赖性血小板聚集所需的糖蛋白IIb-IIIa受体的表达速率,以对聚集异常提供更直接的分子解释。我们使用血小板聚集仪和颗粒计数来监测微聚集,比较了ADP活化血小板的聚集动力学。使用流式细胞术,用异硫氰酸荧光素(FITC)标记的人Fg和活化的糖蛋白IIb-IIIa的报告抗体FITC-PAC1监测纤维蛋白原受体的表达。受影响的血小板在用人类Fg搅拌的ADP活化血小板的微聚集开始时出现明显延迟,同时在原本有能力结合Fg的情况下,活化的糖蛋白IIb-IIIa受体表达出现异常延迟(DARE)。对于用佛波酯(PMA)最大程度预活化的血小板,无论比较人Fg还是牛Fg的结合,正常和受影响血小板的Fg结合速率常数是相同的。独特的DARE综合征解释了受影响的西门塔尔牛血小板聚集延迟的现象,并预测了由于粘附蛋白结合延迟导致的出血问题。